Income Statement (TTM)
MeVis Medical Solutions AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17 | 17 | 17 | 16 | 16 | 16 | 17 | 18 | 19 | 19 | 19 | 18 | 17 | 17 | 18 | 17 | 17 | 17 | 17 |
| Change (%) | -1.74 | -1.77 | -0.97 | -0.98 | 1.44 | 1.42 | 6.24 | 5.87 | -0.20 | -0.20 | -3.60 | -3.74 | 0.87 | 0.86 | -1.91 | -1.94 | -0.99 | -1.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 11 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 |
| Change (%) | -1.18 | -1.19 | 1.83 | 1.80 | 0.61 | 0.61 | 4.06 | 3.90 | 1.89 | 1.86 | -1.01 | -1.03 | 1.82 | 1.79 | -0.82 | -0.83 | 0.81 | 0.81 | |
| % of Revenue | 53.58 | 53.89 | 54.21 | 55.74 | 57.30 | 56.83 | 56.38 | 55.22 | 54.20 | 55.33 | 56.47 | 57.99 | 59.62 | 60.18 | 60.73 | 61.40 | 62.09 | 63.23 | 64.38 |
| Gross Operating Profit | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 8 | 9 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 6 | 6 | 6 |
| Change (%) | -2.39 | -2.45 | -4.28 | -4.47 | 2.54 | 2.48 | 9.06 | 8.30 | -2.67 | -2.74 | -6.96 | -7.48 | -0.53 | -0.53 | -3.58 | -3.71 | -3.94 | -4.11 | |
| % of Revenue | 46.42 | 46.11 | 45.79 | 44.26 | 42.70 | 43.17 | 43.62 | 44.78 | 45.80 | 44.67 | 43.53 | 42.01 | 40.38 | 39.82 | 39.27 | 38.60 | 37.91 | 36.77 | 35.62 |
| SG&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -0.11 | -0.11 | 3.86 | 3.72 | -3.07 | -3.17 | 12.76 | 11.32 | 1.26 | 1.24 | -0.96 | -0.96 | 0.63 | 0.62 | 0.41 | 0.41 | 0.79 | 0.78 | |
| % of Revenue | 2.56 | 2.61 | 2.65 | 2.78 | 2.91 | 2.78 | 2.65 | 2.82 | 2.96 | 3.01 | 3.05 | 3.13 | 3.22 | 3.22 | 3.21 | 3.28 | 3.36 | 3.42 | 3.48 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 12 | 12 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 13 | 13 | 13 | 12 | 13 | 13 | 13 | 13 | 13 | 13 |
| Change (%) | -0.35 | -0.35 | -1.26 | -1.28 | -0.65 | -0.65 | 5.62 | 5.32 | 2.19 | 2.15 | -1.39 | -1.41 | 1.76 | 1.73 | 0.28 | 0.28 | 1.07 | 1.06 | |
| % of Revenue | 67.53 | 68.48 | 69.48 | 69.27 | 69.06 | 67.64 | 66.27 | 65.88 | 65.54 | 67.10 | 68.68 | 70.26 | 71.95 | 72.58 | 73.21 | 74.84 | 76.54 | 78.13 | 79.75 |
| Operating Income | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 |
| Change (%) | -4.64 | -4.86 | -0.30 | -0.30 | 6.08 | 5.73 | 7.46 | 6.94 | -4.74 | -4.98 | -8.45 | -9.23 | -1.40 | -1.42 | -7.88 | -8.56 | -7.70 | -8.35 | |
| % of Revenue | 32.47 | 31.52 | 30.52 | 30.73 | 30.94 | 32.36 | 33.73 | 34.12 | 34.46 | 32.90 | 31.32 | 29.74 | 28.05 | 27.42 | 26.79 | 25.16 | 23.46 | 21.87 | 20.25 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||||||||
| Change (%) | -66.34 | -99.14 | -0.00 | -0.00 | |||||||||||||||
| % of Revenue | -0.02 | -0.01 | -0.24 | -1.20 | -0.01 | -0.01 | -0.01 | ||||||||||||
| Net Income | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 8 | 7 | 6 | 6 | 5 | 5 | 6 | 5 | 5 | 4 | 4 |
| Change (%) | -4.95 | -5.20 | -5.78 | -6.13 | 11.06 | 9.96 | 20.16 | 16.78 | -10.22 | -11.38 | -10.31 | -11.49 | 8.46 | 7.80 | -10.35 | -11.55 | -2.83 | -2.91 | |
| % of Revenue | 33.30 | 32.21 | 31.09 | 29.58 | 28.04 | 30.69 | 33.28 | 37.64 | 41.52 | 37.35 | 33.16 | 30.85 | 28.37 | 30.50 | 32.60 | 29.79 | 26.87 | 26.37 | 25.87 |
Source: Capital IQ
